Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase I/II Evaluation of ANG Modification of 5-FU and MITO Toxicity for Unresectable Colorectal and Refractory Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								MDA-DM-8204


2.		Phase II Chemotherapy with Anguidine for Refractory Stage IV Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MDA-MBDT-7801


3.		Phase II Chemotherapy with Anguidine for Pediatric and Adolescent Acute Lymphoblastic Leukemia in Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 21				NCI				POG-7810


4.		Phase II Chemotherapy with Cyclic Daily Anguidine for Gastrointestinal Tract Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								SEG-77GI0202 SEG-77GI221


5.		Phase II Study of Chemotherapy with Anguidine for Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								SEG-77ST219 SEG-77ST0102


6.		Phase II Study of Anguidine Chemotherapy for Advanced Soft Tissue and Bony Sarcomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7731


7.		Phase II Chemotherapy with Anguidine for Advanced Gastrointestinal Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7735


8.		Phase II Chemotherapy with Anguidine for Urological Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7736


9.		Phase II-Pilot Chemotherapy with Anguidine for Acute Nonlymphocytic Leukemia Refractory to Standard Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 21				NCI				SWOG-8063


10.		Pilot Phase II Study with Anguidine to Prevent Myelosuppression in Patients with Leukemia and Solid Tumors Treated with ARA-C

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								MDA-DT-7977P

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute